Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Oncology
Biotech
Regeneron cell medicines chief is crafting a new 'secret sauce'
Phil Gregory’s new gig looks a whole lot like his old gig. It’s just that, under the umbrella of Regeneron, things have gotten a bit bigger.
Annalee Armstrong
May 9, 2024 5:00am
Pepper spices up pipeline with $135M deal for G1's cancer drug
May 1, 2024 10:32am
Barinthus HPV drug doesn't prove efficacy
Apr 19, 2024 9:50am
Cullinan rebrands, halts lymphoma trial in autoimmune refocus
Apr 16, 2024 10:05am
Boundless boldly goes public with $100M IPO
Mar 28, 2024 7:10am
Theratechnologies sheds preclinical oncology research programs
Mar 25, 2024 5:30am
More News
Pfizer revamps oncology R&D strategy
Feb 29, 2024 6:03pm
A new biotech blooms with $100M to take on small molecules
Feb 29, 2024 9:30am
SCRI and AstraZeneca to collab on cancer clinical trials
Feb 29, 2024 7:05am
4 Big Pharmas recruit Biofourmis for cancer trials
Feb 14, 2024 3:30pm
See more stories